Stimcell Energetics (STME) Profit After Tax Growth (3y) (2016 - 2026)
Stimcell Energetics (STME) Profit After Tax Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 2.68% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 62.16% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.79% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 60.12% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.38% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 30.83% |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | 4.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 4.92% |
| Nov 30, 2025 | -29.44% |
| Aug 31, 2025 | -19.75% |
| May 31, 2025 | -9.03% |
| Feb 28, 2025 | -2.30% |
| Nov 30, 2024 | 3.34% |
| Aug 31, 2024 | 27.43% |
| May 31, 2024 | 34.24% |
| Feb 29, 2024 | 37.02% |
| Nov 30, 2023 | 32.46% |
| Aug 31, 2023 | 33.19% |
| May 31, 2023 | 20.92% |
| Feb 28, 2023 | 33.06% |
| Nov 30, 2022 | 22.18% |
| Aug 31, 2022 | 15.04% |
| May 31, 2022 | -8.05% |
| Feb 28, 2022 | 30.74% |
| Nov 30, 2021 | -8.47% |
| Aug 31, 2021 | 10.30% |
| May 31, 2021 | 16.88% |